婦科合作與授權協議（2016-2025）

"婦科合作與許可協議報告" 以前所未有的方式，全面深入地展現了全球領先的生物製藥公司達成的婦科交易。

本報告詳細介紹了2016年至2025年間達成的150項婦科交易。

本報告提供了交易雙方已公佈的付款條款。這些數據有助於深入了解付款條款和其他交易條款。

了解潛在合作夥伴協商條款的彈性，有助於深入了解談判過程，以便更好地預期談判結果。雖然許多中小企業會尋求詳細的付款條款，但魔鬼藏在細節裡，尤其是在付款方式和權利轉讓方面。

本報告全面列出了自 2016 年以來在 "當前協議" 交易和合作資料庫中記錄的所有合作與許可協議，並附有財務條款（如有），以及公司及其合作夥伴向美國證券交易委員會提交的實際許可協議文件的在線鏈接。

本報告第一章探討了婦科領域的交易和商業活動。第一章為報告的引言，第二章分析了婦科領域的交易趨勢。

第三章介紹了婦科領域已達成交易的財務條款及其所處的研發階段。交易清單按總金額、首付款、里程碑付款和特許權使用費率進行分類。

第四章回顧了婦科領域最活躍的 25 家生物製藥公司。對於已公開揭露協議的交易，可透過 "目前協議交易與聯盟" 資料庫線上存取這些協議。

第五章對自 2016 年以來簽署和宣布的婦科交易進行了全面深入的回顧，這些交易的協議文件均可查閱。每個交易標題都透過網路連結指向實際的線上協議文件，方便讀者根據需要輕鬆存取每個協議文件。

第六章按目標公司提供了婦科交易的完整目錄。

本書也包含大量圖表，展示了自 2016 年以來婦科交易的趨勢和活動。

此外，本書還提供了一個以公司名稱（A-Z）和技術類型組織的綜合交易目錄。每個交易標題都透過網路連結指向線上交易記錄，並包含協議文件（如有），方便讀者隨時按需存取每個協議文件。

主要優勢

婦科合作研究和授權協議為讀者提供以下主要優勢：

• 了解自 2016 年以來的交易趨勢
• 查看婦科合作與許可交易
• 基準分析 - 確定交易市場價值
• 財務條款 - 預付款、里程碑付款、特許權使用費
• 按公司 A-Z、治療領域和技術類型分類的交易目錄
• 主要交易金額
• 最活躍的交易撮合者
• 確定每筆交易的資產和交易條款
• 存取合約文件 - 深入了解交易結構
• 盡職調查 - 評估擬議交易條款是否適合您的合作夥伴
• 節省數百小時的研究時間

範圍

• 婦科合作和許可協議報告旨在提供深入的…了解全球領先生物製藥公司簽署的婦科合作與許可協議的趨勢和交易結構。

婦科合作與許可交易包括：

• 生物製藥產業婦科交易趨勢
• 合作與授權交易結構概述
• 涵蓋製藥和生物技術的婦科交易記錄目錄
• 婦科重大交易
• 最活躍的婦科許可交易撮合者

婦科合作與許可交易清單列出了所有可用的交易。

• 公司 A-Z
• 交易金額
• 治療領域
• 技術類型
• 每個交易標題都透過網路連結連結到實際的線上交易記錄，方便查閱合約文件（如有）。
• 婦科合作與許可交易資料庫提供全面的交易記錄存取權限，包括合約文件。

合約分析有助於對以下方面進行盡職調查：

• 具體授予或選擇哪些權利？
• 合約夥伴實際獲得哪些權利？
• 授予哪些獨家經營權？
• 合約的付款結構是什麼？
• 如何進行銷售和付款審計？
• 合約期限是多久？
• 如何定義合約的關鍵條款？
• 如何處理並擁有知識產權？
• 誰負責商業化？
• 誰負責開發、供應和生產？
• 如何管理保密性和資訊揭露？
• 如何解決爭議？
• 在什麼情況下可以終止合約？
• 如果所有權發生變更，會發生什麼事？
• 已達成哪些轉許可或分包條款？
• 公司堅持哪些標準條款？
• 哪些格式條款似乎會因合作夥伴和交易類型而異？
• 公司主張適用哪個契約法管轄區？

目錄

摘要整理

第一章：引言

第二章：婦科交易趨勢

• 引言
• 歷年婦科合作狀況
• 以交易類型劃分的婦科合作
• 按行業劃分的婦科合作
• 依研發階段劃分的婦科合作
• 以技術類型劃分的婦科合作
• 依治療適應症劃分的婦科合作

第三章 婦科合作的財務條款

• 引言
• 揭露婦科合作的財務條款
• 主要價值婦科合作
• 婦科交易中的預付款
• 婦科交易中的里程碑付款
• 婦科專利費率

第四章 - 婦科關鍵交易及交易商

• 引言
• 婦科合作中最活躍的交易商
• 最活躍的婦科交易撮合者名單
• 以價格排名的頂級婦科交易

第五章 - 婦科合約文件目錄

• 引言
• 提供合約的婦科合作交易

第六章 依治療標靶劃分的婦科交易

• 引言
• 依婦科治療標靶劃分的交易
• 交易目錄
• 交易目錄 - 婦科交易（按公司、亞利桑那州、2016-2025 年）
• 交易目錄 - 婦科交易（依技術類型、2016-2025 年）
• 交易類型定義
• 關於研究公司
• 當前合作夥伴
• 當前協議
• 按目前合作夥伴分類的當前報告標題

Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gynecology deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of 150 gynecology deals from 2016 to 2025.

The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration and licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of gynecology dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in gynecology dealmaking.

Chapter 3 covers the financial deal terms for deals signed in the gynecology field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.

Chapter 4 provides a review of the top 25 most active biopharma companies in gynecology dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive and detailed review of gynecology deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of gynecology deals listed by theraeutic target.

The report also includes numerous table and figures that illustrate the trends and activities in gynecology deal making since 2016.

In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Gynecology Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse gynecology collaboration and licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Gynecology Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of gynecology trends and structure of deals entered into by leading biopharma companies worldwide.

Gynecology Collaboration and Licensing Deals includes:

• Trends in gynecology dealmaking in the biopharma industry
• Overview of collaboration and licensing deal structure
• Directory of gynecology deal records covering pharmaceutical and biotechnology
• The leading gynecology deals by value
• Most active gynecology licensing dealmakers

In Gynecology Collaboration and Licensing Deals, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Gynecology Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in gynecology dealmaking

• 2.1. Introduction
• 2.2. Gynecology partnering over the years
• 2.3. Gynecology partnering by deal type
• 2.4. Gynecology partnering by industry sector
• 2.5. Gynecology partnering by stage of development
• 2.6. Gynecology partnering by technology type
• 2.7. Gynecology partnering by therapeutic indication

Chapter 3 - Financial deal terms for gynecology partnering

• 3.1. Introduction
• 3.2. Disclosed financials terms for gynecology partnering
• 3.3. Gynecology partnering headline values
• 3.4. Gynecology deal upfront payments
• 3.5. Gynecology deal milestone payments
• 3.6. Gynecology royalty rates

Chapter 4 - Leading gynecology deals and dealmakers

• 4.1. Introduction
• 4.2. Most active in gynecology partnering
• 4.3. List of most active dealmakers in gynecology
• 4.4. Top gynecology deals by value

Chapter 5 - Gynecology contract document directory

• 5.1. Introduction
• 5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

• 6.1. Introduction
• 6.2. Deals by gynecology therapeutic target
• Deal directory
• Deal directory - Gynecology deals by company A-Z 2016 to 2025
• Deal directory - Gynecology deals by technology type 2016 to 2025
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Gynecology partnering since 2016
• Figure 2: Gynecology partnering by deal type since 2016
• Figure 3: Gynecology partnering by industry sector since 2016
• Figure 4: Gynecology partnering by stage of development since 2016
• Figure 5: Gynecology partnering by technology type since 2016
• Figure 6: Gynecology partnering by indication since 2016
• Figure 7: Gynecology deals with a headline value
• Figure 8: Gynecology deals with upfront payment values
• Figure 9: Gynecology deals with milestone payment
• Figure 10: Gynecology deals with royalty rates
• Figure 11: Active gynecology dealmaking activity since 2016
• Figure 12: Top gynecology deals by value since 2016